Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

274 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Catalytic subunit of human telomerase reverse transcriptase is an independent predictor of survival in patients undergoing curative resection of hepatic colorectal metastases: a multicenter analysis.
Dômont J, Pawlik TM, Boige V, Rose M, Weber JC, Hoff PM, Brown TD, Zorzi D, Morat L, Pignon JP, Rashid A, Jaeck D, Sabatier L, Elias D, Tursz T, Soria JC, Vauthey JN. Dômont J, et al. Among authors: tursz t. J Clin Oncol. 2005 May 1;23(13):3086-93. doi: 10.1200/JCO.2005.06.944. J Clin Oncol. 2005. PMID: 15860868
DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy.
Olaussen KA, Dunant A, Fouret P, Brambilla E, André F, Haddad V, Taranchon E, Filipits M, Pirker R, Popper HH, Stahel R, Sabatier L, Pignon JP, Tursz T, Le Chevalier T, Soria JC; IALT Bio Investigators. Olaussen KA, et al. Among authors: tursz t. N Engl J Med. 2006 Sep 7;355(10):983-91. doi: 10.1056/NEJMoa060570. N Engl J Med. 2006. PMID: 16957145 Free article. Clinical Trial.
Phase II study of pirarubicin in advanced non-small cell lung cancer.
Berthaud P, Le Chevalier T, Berille J, Herait P, Baldeyrou P, Tursz T, Arriagada R, Spielmann M, Hayat M. Berthaud P, et al. Among authors: tursz t. Eur J Cancer Clin Oncol. 1989 Sep;25(9):1337-8. doi: 10.1016/0277-5379(89)90082-5. Eur J Cancer Clin Oncol. 1989. PMID: 2553419 No abstract available.
Phase II study of pirarubicin in advanced non-small cell lung cancer.
Berthaud P, Le Chevalier T, Berille J, Herait P, Baldeyrou P, Tursz T, Arriagada R, Spielmann M, Hayat M. Berthaud P, et al. Among authors: tursz t. Eur J Cancer Clin Oncol. 1989 Oct;25(10):1507-8. doi: 10.1016/0277-5379(89)90113-2. Eur J Cancer Clin Oncol. 1989. PMID: 2556281 No abstract available.
[Results of a randomized study comparing combination of navelbine-cisplatin to combination of vindesine-cisplatin and to navelbine alone in 612 patients with inoperable non-small cell lung cancer].
Le Chevalier T, Brisgand D, Pujol JL, Douillard JY, Monnier A, Rivière A, Chomy P, Le Groumellec A, Ruffie P, Gottfried M, Gaspard MH, Chevreau C, Alberola V, Cigolari S, Besson F, Martinez A, Besenval M, Berthaud P, Tursz T. Le Chevalier T, et al. Among authors: tursz t. Bull Cancer. 1996 May;83(5):385-94. Bull Cancer. 1996. PMID: 8680091 Clinical Trial. French.
274 results